Mineralys Therapeutics, Inc.

MLYS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $2.4B · 76 employees
65
SEC Filings
$30.01
Close 2026-05-27
76
Employees

Business Summary

Part I Business Overview We are a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. Our product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor (ASI) that we are developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities such as chronic kidney disease (CKD) and obstructive sleep apnea (OSA...

Latest Stock Quote

MLYS 2026-05-27 $30.01 O:$30.32 H:$30.42 L:$29.4 Vol:1.2M VWAP:$29.976
origin leaf: 04d40c3b99ee264aeef17cb94f09b480f608782c30a6121017ba5172f28fce31

Next Earnings

Q2 FY2026 — expected 2026-09-10

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001933414-26-000056EDGAR77K words
2025-02-122024-12-310001933414-25-000009EDGAR—
2024-03-212023-12-310001628280-24-012358EDGAR—
2023-03-152022-12-310001933414-23-000012EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001933414-25-000142EDGAR21K words
2025-08-122025-06-300001933414-25-000090EDGAR—
2025-05-122025-03-310001933414-25-000058EDGAR—
2024-11-122024-09-300001933414-24-000057EDGAR—
2024-08-132024-06-300001933414-24-000039EDGAR—
2024-05-092024-03-310001933414-24-000016EDGAR—
2023-11-072023-09-300001933414-23-000087EDGAR—
2023-08-072023-06-300001933414-23-000056EDGAR—
2023-05-152023-03-310001933414-23-000038EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-120001933414-26-000054EDGAR2K words
2026-03-090001933414-26-000048EDGAR—
2026-01-060001933414-26-000002EDGAR—
2025-11-100001933414-25-000139EDGAR—
2025-09-030001933414-25-000120EDGAR—
2025-09-020001933414-25-000107EDGAR—
2025-08-120001933414-25-000088EDGAR—
2025-06-170001933414-25-000070EDGAR—
2025-05-220001933414-25-000064EDGAR—
2025-05-120001933414-25-000057EDGAR—

65 total filings indexed. 42 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001933414
TickerMLYS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://mineralystx.com
Listed2023-02-10

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ae7dd51e87da419d4f2ae9752a2a6a87172ab4846b46fd2fc98a56f2c38cbb06
parent: feb62209bee23cd885e9c0c6670d79766cc0b7633e0f2c39075001fc72bde6ad
content hash: fdc110acd8eb25f3a7a9fcead4badc1c0a2322399d4d73d0896f9f1e5c7b8a15
signed: 2026-06-03T12:01:52.098Z
sources: 14 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf